propranolol has been researched along with Essential Hypertension in 1 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Essential Hypertension: Hypertension that occurs without known cause, or preexisting renal disease. Associated polymorphisms for a number of genes have been identified, including AGT, GNB3, and ECE1. OMIM: 145500
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kurćubić, I | 1 |
| Vajić, UJ | 1 |
| Cvijić, S | 1 |
| Crevar-Sakač, M | 1 |
| Bogavac-Stanojević, N | 1 |
| Miloradović, Z | 1 |
| Mihajlović-Stanojević, N | 1 |
| Ivanov, M | 1 |
| Karanović, D | 1 |
| Jovović, Đ | 1 |
| Djuriš, J | 1 |
1 other study available for propranolol and Essential Hypertension
| Article | Year |
|---|---|
Mucoadhesive buccal tablets with propranolol hydrochloride: Formulation development and in vivo performances in experimental essential hypertension.
Topics: Adhesiveness; Administration, Buccal; Animals; Essential Hypertension; Mouth Mucosa; Propranolol; Ra | 2021 |